RIPK3 and breast carcinoma: A clinical study of breast cancer tissue specimens showed that compared to adjacent non-cancerous tissues, the mRNA and protein expression levels of tumor necrosis factor alpha (TNFα), RIPK1, RIPK3, and MLKL were significantly elevated in breast cancer tissues.